Sabag Mark Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
6
Insider Sells Sum
$9.17M

Insider Activity of Sabag Mark

According to the SEC Form 4 filings, Sabag Mark, being in a position of

  1. See "Remarks" at Teva Pharmaceutical Industries Limited,
    оver the last 12 months, has bought 0 shares, and sold 423174 shares for $13.15M,
    over all time since 2018-02-14, has bought 0 shares, and sold 1447564 shares for $28.42M.

Biography of Sabag Mark

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$13,147,6883100

Comparison of Insiders on Amount of Buys and Sells

2026-05-01SaleTeva Pharmaceutical Industries Limited
TEVA
See "Remarks"
144,180
0.0124%
$34.99$5.05M+2.82%
2026-03-17SaleTeva Pharmaceutical Industries Limited
TEVA
See "Remarks"
62,102
0.0053%
$30.14$1.87M+15.37%
2025-12-09SaleTeva Pharmaceutical Industries Limited
TEVA
See "Remarks"
216,892
0.019%
$28.73$6.23M+19.22%
2025-05-08SaleTeva Pharmaceutical Industries Limited
TEVA
See "Remarks"
337,915
0.0294%
$18.04$6.1M+33.98%
2025-02-12SaleTeva Pharmaceutical Industries Limited
TEVA
See "Remarks"
177,626
0.0153%
$16.25$2.89M+9.91%
2024-03-05SaleTeva Pharmaceutical Industries Limited
TEVA
EVP, International Markets
100,000
0.0089%
$13.52$1.35M+25.89%
2021-03-16SaleTeva Pharmaceutical Industries Limited
TEVA
See "Remarks" below
254,488
0.0234%
$11.22$2.86M-15.41%
2020-02-13SaleTeva Pharmaceutical Industries Limited
TEVA
See "Remarks" below
144,261.08
0.0137%
$13.03$1.88M-17.7%
2018-02-15SaleTeva Pharmaceutical Industries Limited
TEVA
EVP, Global Human Resources
6,000
0.0006%
$20.52$123,120+1.83%
2018-02-14SaleTeva Pharmaceutical Industries Limited
TEVA
EVP, Global Human Resources
4,100
0.0004%
$18.45$75,645+9.62%
Total: 10
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.